179

Bibliography

180

Abhilash PC, Singh N. (2009). Pesticide use and application: An Indian scenario. J Hazard Mater. 165, 1–12.

Ackerman WE 4th, Summerfield TL, Vandre DD, Robinson JM, Kniss DA. (2008). Nuclear factor-kappa B regulates inducible prostaglandin E synthase expression in human amnion mesenchymal cells. Biol Reprod. 78, 68-76.

ACS, (2008). Cancer Projected To Become Leading Cause Of Death Worldwide In 2010. ScienceDaily. Retrieved March 14, 2011, from http://www.sciencedaily.com /releases/2008/12/081209111516.htm

Adelstein DJ, Sharan VM, Earle AS, Shah AC, Vlastou C, Haria CD. (1990). Longterm results after chemoradiotherapy for locally confined squamous-cell head and neck cancer. Am J Clin Oncol. 13, 440–447.

Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. (1998). Developmentally regulated expression of the novel cancer antiapoptosis gene survivin in human and mouse differentiation. Am J Pathol. 152, 43–49.

Adida C, Haioun C, Gaulard P. (2000). Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood. 96, 1921-1925.

Adler V, Yin Z, Tew KD, Ronai Z. (1999). Role of redox potential and reactive oxygen species in stress signaling. Oncogene.18, 6104-6111.

Aeschbach R, Löliger J, Scott BC, Murcia A, Butler J, Halliwell B, Aruoma OI. (1994). Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem. Toxicol. 32, 31-36.

Afaq F, Adhami VM, Ahmad N, Mukhtar H. (2003). Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene. 22, 1035–1044.

Aggarwal BB. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell. 6, 203–208.

Aggarwal BB., Shishodia S. (2006). Molecular target of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 71, 1397–1421.

Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. (2006). Inflammation and cancer: How hot is the link?. Biochem Pharmacol. 72, 1605 -1621.

Ahmed RS, Seth V, Pasha ST, Banerjee BD. (2000a). Influence of dietary ginger (Zingiber officinales Rosc) on oxidative stress induced by malathion in rats. Food Chem Toxicol. 38, 443-450.

Ahmed RS, Seth V, Banerjee BD. (2000b). Influence of dietary ginger (Zingiber officinales Rosc) on antioxidant defense system in rat: comparison with ascorbic acid. Indian J Exp Biol. 38, 604-606.

Ahmed RS, Suke SG, Seth V, Chakraborti A, Tripathi AK, Banerjee BD. (2008). Protective effects of dietary ginger (Zingiber officinales Rosc.) on lindane-induced oxidative stress in rats. Phytother Res. 22, 902-906.

Ahn JH, Park SN, Yum YN, Kim JY, Lee M. (2008). Comparison of In Vitro Cell Transformation Assay Using Murine Fibroblasts and Human Keratinocytes. Toxicol Res. 24, 37-44.

Ahnstrom G, Erixon K. (1973). Radiation induced strand breakage in DNA from mammalian cells. Strand separation in alkaline solution. Int J Radiat Biol. 23, 285-289.

Ahonen LJ, Kallio MJ, Daum JR. (2005). Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and modulates the association of spindle-checkpoint proteins at kinetochores. Curr Biol. 15, 1078-1089.

Alas S, Bonavida B. (2001). Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res. 61, 5137-5144.

181

Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K. (2000). IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat Res. 463, 111–172.

Alexopoulos CJ, Mims CW, Blackwell M. (1996). Introductory Mycology. John Wiley and Sons, Inc., New York. 717-723.

Altieri DC. (2003a). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene. 22, 8581–8589.

Altieri DC. (2003b). Validating survivin as a cancer therapeutic target. Nat Rev Cancer. 3, 46-54.

Altieri DC, Marchisio PC. (1999). Survivin apoptosis: an interloper between cell death, cell proliferation in cancer. Lab Invest. 79, 1327–1333.

Alvarez B, Martinez AC, Burgering BM, Carrera AC. (2001). Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature. 413, 744-747.

Ambrosini G, Adida C, Altieri DC. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 3, 917-921.

Amin AR, Paul RK, Thakur VS, Agarwal ML. (2007a). A novel role for p73 in the regulation of Akt-Foxo1a-Bim signaling and apoptosis induced by the plant lectin, Concanavalin A. Cancer Res. 67, 5617–5621.

Amin AR, Thakur VS, Paul RK, Feng GS, Qu CK, Mukhtar H, Agarwal ML. (2007b). SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG. Proc Natl Acad Sci. USA. 104, 5419–5424.

Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB. (2008). Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 25, 2097-2116. Review.

Anderson HJ, Andersen RJ, Roberge M. (2003). Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy. Prog Cell Cycle Res. 5, 423–430.

Ando K, Ozaki T, Yamamoto H, Furuya K, Hosoda M, Hayashi S, Fukuzawa M, Nakagawara A. (2004). Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation. J Biol Chem. 279, 25549–25561.

Antonyak MA, Moscatello DK, Wong AJ. (1998). Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor. J Biol Chem. 273, 2817–2822.

Arora A, Kalra N, Shukla Y. (2006). Regulation of p21/ras protein expression by diallyl sulfide in DMBA induced neoplastic changes in mouse skin. Cancer Lett. 42, 28-36.

Arora A, Shukla Y. (2002). Induction of apoptosis by diallyl sulfide in DMBA-induced mouse skin tumors. Nutr. Cancer. 44, 89–94.

Aschengrau A., Ozonoff D., Coogan P, Vezina R, Heeren T, Zhang Y. (1996). Cancer risk and residential proximity to cranberry cultivation in Massachusetts. Am J Public Health. 86, 1289-1296.

Ashihara E, Kawata E, Maekawa T. (2010). Future prospect of RNA interference for cancer therapies. Curr Drug Targets. 11, 345-360. Review.

Ashihara E, Kawata E, Nakagawa Y. (2009). Beta-catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model. Clin Cancer Res. 15, 2731-2738.

Azuma H, Inamoto T, Takahara K, Ibuki N, Koyama K, Utimoto S, Fujisue Y, Uehara H, Komura K, Nomi H, Ubai T, Katsuoka Y. (2010). Combination therapy with VP16 and ethinylestradiol for hormone-refractory prostate cancer: good response with tolerability. Anticancer Res. 30, 3737-3745.

Bukowska B. (2003). Effects of 2, 4-D and its metabolite 2,4-dichlorophenol on antioxidant enzymes and level of glutathione in human erythrocytes. Comp Biochem Physiol C Toxicol Pharmacol. 135, 435- 441.

Banerjee BD, Seth V, Bhattacharya A, Pahsa ST, Chacraborty AK. (1999). Biochemical effects of some pesticides on lipid peroxidation and freeradical scavengers. Toxicol Lett. 107, 33 - 47.

182

Babu GJ, Lalli MJ, Sussman MA, Sadoshima J, Periasamy M. (2000). Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy. J Mol Cell Cardiol. 32, 1447-1457.

Baeuerle P, Henkel T. (1994) Function and activation of NF-kB in the immune system. Annu. Rev. Immunol. 12, 141–179.

Baeuerle PA, Baltimore D. (1996). NF-kB: ten years after. Cell. 87, 13–20.

Bagnyukova TV, Serebriiskii IG, Zhou Y, Hopper-Borge EA, Golemis EA, Astsaturov I. (2010). Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents? Cancer Biol Ther. 10, 839-853.

Baligar PN, Kaliwar BB. (2001). Induction of Gonadal Toxicity to Female Rats after Chronic Exposure to Mancozeb. Industrial Health. 39, 235–243.

Banerjee BD, Seth V, Ahmed RS. (2001). Pesticide-induced oxidative stress: perspectives and trends. Rev Environ Health. 16, 1-40.

Barnes PJ. Karin M. (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 336, 1066–1071.

Barr FA, Sillje HH, Nigg EA. (2004). Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol. 5, 429- 440.

Barrett JC. (1993). Mechanisms of Multistep Carcinogenesis and Carcinogen Risk Assessment. Environ Health Perspect. 100, 9-20.

Barrett JC, Fletcher WF. (1987). Cellular and molecular mechanisms of multistep carcinogenesis in cell culture models. In: Mechanisms of Environmental Carcinogenesis: Multistep Models of Carcinogenesis, (Barrett JC ed.). CRC Press, Boca Raton, Florida. Vol. 2, pp. 73-116.

Barrett JC, Kakunaga T, Kuroki T, Neubert D, Trosko JE, Vasiliev JM, Williams GM, Yamasaki H. (1986). Short-term assays to predict carcinogenicity. In vitro assays that may be predictive of tumour-promoting agents. IARC Sci Publ. 83, 287-302.

Bartlett DW, Davis ME. (2008). Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles. Biotechnol Bioeng. 99, 975-985.

Bassil KL, Vakil C, Sanborn M, Cole DC, Kaur JS, Kerr KJ. (2007). Cancer health effects of pesticides: systematic review. Can Fam Physician. 53, 1704–1711.

Basu S., Kolesnick R. (1998). Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene. 17, 3277-3285.

Beg T, Siddique YH, Afzal M. (2007). Antigenotoxic potential of gingerol in cultured mammalian cells. The Icfai J Life Sci. 1, 39-44.

Beg T, Siddique YH, Ara G, Gupta J, Afzal M. (2008). Antigenotoxic effect of genistein and gingerol on genotoxicity induced by norethandrolone and oxandrolone in cultured human lymphocytes. Int J Pharmacol. 4, 177-183.

Behlke MA. (2008). Chemical modification of siRNAs for in vivo use. Oligonucleotides. 18, 305-319.

Bell HS, Dufes C, O’Prey J, Crighton D, Bergamaschi D, Lu X, Schätzlein AG, Vousden KH, Ryan KM. (2007). A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo. J Clin Invest. 117, 1008–1018.

Belpoggi F, Soffritti M, Guarino M, Lambertini L, Cevolani D, Maltoni C. (2002). Results of long-term experimental studies on the carcinogenicity of ethylene-bis-dithiocarbamate (Mancozeb) in rats. Ann N Y Acad Sci. 982, 123-136.

Benard J, Douc-Rasy S, Ahomadegbe JC. (2003). TP53 family members and human cancers. Hum Mutat. 21, 182–191.

Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G. (2003). p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell. 3, 387–402.

183

Berwald Y, Sachs L. (1965). In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J Natl Cancer Inst. 35, 641-61.

Bhimani RS, Troll W, Grunberger D, Frenkel K. (1993). Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res. 53, 4528–4533.

Bhui K, Tyagi S, Prakash B, Shukla Y (2010). Pineapple bromelain induces autophagy, facilitating apoptotic response in mammary carcinoma cells. Biofactors. 36, 474-482.

Bhui K, Prasad S, George J, Shukla Y. (2009). Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway. Cancer Lett. 282, 167-176.

Blasiak J, Stańkowska D. (2001).Genotoxicity of Malaoxon: Induction of Oxidized and Methylated Bases and Protective Effect of α-Tocopherol. Pestic Biochem Physiol. 71, 88-96.

Bode AM, Ma WY, Surh YJ, Dong Z. (2001). Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res. 61, 850-853.

Bolcsfoldi G. (1995). The DNA alkaline unwinding genotoxicity test. In: Methods in Molecular Biology. (O'Hare S., Atterwill C.K. e.ds.). Humana Press Inc, Totowa, NJ. Vol 43, 257-266.

Bolognesi C. (2003). Genotoxicity of pesticides: a review of human biomonitoring studies. Mutat Res. 543, 251–272.

Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Cebulska-Wasilewska A, Fabianova, Fucic A, Hagmar L, Joksic G, Martelli, L.Migliore A, Mirkova E, Scarfi MR, Zijno A, Norppa H, Fenech M. (2007). An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis. 28, 625-631.

Böni R, Burg G, Doguoglu A, Ilg EC, Schäfer BW, Müller B, Heizmann CW. (1997). Immunohistochemical localization of the Ca

2+ binding S100 proteins in normal human skin and

melanocytic lesions. Br J Dermatol. 137, 39-43.

Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC. (1993). p53 Is Mutated in a Subset of Advanced-Stage Prostate Cancers. Cancer Res. 53, 3369-3373.

Boone B, Blokx W, De Bacquer D, Lambert J, Ruiter D, Brochez L. (2008). The role of VEGF-C staining in predicting regional metastasis in melanoma. Virchows Arch. 453, 257-265.

Borenfreund EC, Tang K. (2003). Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organisation in vitro. J Cell Biochem. 88, 848–854.

Borenfreund E, Puerner J. (1985). Toxicity determination in vitro by morphological alterations and neutral red absorption. Toxicol Lett. 24, 119-124.

Boros J, Donaldson IJ, O'Donnell A, Odrowaz ZA, Zeef L, Lupien M, Meyer CA, Liu XS, Brown M, Sharrocks AD. (2009). Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res.19, 1963-1973.

Bottini AA, Alepee N, Phillips B, Gribaldo L, De Silva O, Hartung T, Hendriksen C, Kuil J, Pazos P, Rhein C, Schiffelers MJ, Stokes W, Theobald A, Vidal JM, Van de Sandt H, Breier S, Sintes JR, Blaauboer B. (2008). Optimisation of the post-validation process: the report and recommendations of ECVAM Workshop 67. Altern Lab Anim. 36, 353-366.

Boukamp P, Popp S, Altmeyer S, Hülsen A, Fasching C, Cremer T, Fusenig NE. (1997). Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT. Genes Chromosomes Cancer. 19, 201-214.

Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 106, 761-771.

Bours V, Bonizzi G, Bentires-Alj M, Bureau F, Piette J, Lekeux P, Merville M. (2000). NF-kB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment. Toxicology. 153, 27–38.

184

Boveri M, Boveri T. (1929). The origin of malignant tumors. Williams and Wilkins. Baltimore, Maryland.

Brader S, Eccles SA. (2004). Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori. 90, 2-8.

Bratton MR, Frigo DE, Vigh-Conrad KA, Fan D, Wadsworth S, McLachlan JA, Burow ME. (2009). Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase. Carcinogenesis. 30, 106-113.

Bray F, Moller B. (2006). Predicting the future burden of cancer. Nat Rev Cancer. 6, 63–74.

Breen EC, Tang K. (2003). Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem. 88, 848–854.

Bromberg J. (2002). Stat proteins and oncogenesis. J Clin Invest. 109, 1139-1142.

Bromberg J, Darnell JE Jr. (2000). The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 19, 2468-2473.

Broome AM, Ryan D, Eckert RL. (2003). S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem. 51,675–685.

Bu Y, Yang Z, Li Q, Song F. (2008). Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells. Oncology. 74, 198-206.

Bulavin DV, Fornace AJ Jr. (2004). p38 MAP kinase's emerging role as a tumor suppressor. Adv Cancer Res. 92, 95-118.

Burden AD, Osheroff N. (1998). Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim. Biophys. Acta. 1400, 139–154.

Caglar Y, Kaya M, Belge E, Mete UO. (2003). Ultrastructural evaluation of the effect of endosulfan on mice kidney. Histol Histopathol. 18, 703-708.

Calaf GM, Roy D. (2008). Cancer genes induced by malathion and parathion in the presence of

estrogen in breast cells. Int J Mol Med. 2, 261-268.

Calviello G, Piccioni E, Boninsegna A, Tedesco B, Maggiano N, Serini S, Wolf FI, Palozza P. (2006). DNA damage and apoptosis induction by the pesticide Mancozeb in rat cells: Involvement of the oxidative mechanism. Toxicol Appl Pharmacol. 211, 87–96.

Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, Vecchiato A, Corti L, Rossi CR, Nitti D. (2009). Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol. 16, 191-199.

Carlberg I, Mennervick B. (1985). Glutathione Reductase. In: Methods in Enzymology, (Meister A, ed). New York: Acadmic Press. 113, 484–490.

Cecconi S, Paro R, Rossi G, Macchiarelli G. (2007). The Effects of the Endocrine Disruptors Dithiocarbamates on the Mammalian Ovary with Particular Regard to Mancozeb. Curr Pharm Des. 13, 2989-3004.

Chakravarti A, Noll E, Black PM. (2002). Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol. 20, 1063-1068.

Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, Hui EP, Yiu HY, Yeo W, Cheung FY, Yu KH, Chiu KW, Chan DT, Mok TS, Yau S, Yuen KT, Mo FK, Lai MM, Ma BB, Kam MK, Leung TW, Johnson PJ, Choi PH, Zee BC. (2005). Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 97, 536–539.

Check E. (2005). A crucial test. Nat Med. 11, 243–244.

Chen AG, Yu ZC, Yu XF, Cao WF, Ding F, Liu ZH. (2006a). Overexpression of Ets-like protein 1 in human esophageal squamous cell carcinoma. World J Gastroenterol. 12, 7859-7863.

Chen XH, Lan B, Qu Y, Zhang XQ, Cai Q, Liu BY. (2006b). Inhibitory effect of Polo-like kinase 1 depletion on mitosis and apoptosis of gastric cancer cells. World J Gastroenterol. 12, 29–35.

185

Chen XP, Wang Q, Guan J, Huang ZY, Zhang WG, Zhang BX. (2006c). Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells. World J Gastroenterol. 12, 3332-3337.

Chen YR, Tan TH. (2000). The c-Jun N-terminal kinase pathway and apoptotic signaling. Int J Oncol.16, 651–662.

Chen Z, Varney ML, Backora MW. (2005). Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res. 65, 9004-9011.

Chen G, Hitomi M, Han J, Stacey DW. (2000). The p38 pathway provides negative feedback for Ras proliferative signaling. J Biol Chem. 275, 38973-38980.

Cheng GZ., Chan J., Wang Q., Zhang W., Sun CD., Wang LH. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. 2007. Cancer Res. 67, 1979–1987.

Cho JW, Lee KS, Kim CW. (2007). Curcumin attenuates the expression of IL-1ß, IL-6, and TNF-α as well as cyclin E in TNFα·-treated HaCaT cells; NF-κB and MAPKs as potential upstream targets. Int J Mol Med. 19, 469-474.

Gebhardt C, Breitenbach U, Tuckermann JP, Dittrich BT, Richter KH, Angel P. (2002). Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene. 21, 4266-4276.

Chu IM, Hengst L, Slingerland JM. (2008). The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 8, 253-267.

Clay FJ, McEwen SJ, Bertoncello I, Wilks AF, Dunn AR. (1993). Identification and cloning of a protein kinase-encoding mouse gene, Plk, related to the polo gene of Drosophila. Proc Natl Acad Sci USA. 90, 4882-4886.

Coates P. (2005). Ginger (Zingiber officinale), In: Encyclopedia of Dietary Supplements, (Coates P, Blackman M, Cragg G, Levine M, Moss J, White JD. eds.). Marcel Dekker, New York. 241–248.

Cobb MH, Hepler JE, Cheng M, Robbins D. (1994). The mitogen-activated protein kinases, ERK1 and ERK2. Semin Cancer Biol 5, 261-268.

Colnaghi R, Wheatley SP. (2010). Liaisons between Survivin and PLK1 during cell division and cell death. J. Biol. Chem. 285, 22592-22604.

Combes RD. (1997). Statistical analysis of dose-response data from in vitro assays: An illustration using Salmonella mutagenicity data. Toxicol In Vitro. 11, 683-687.

Coulombe P, Meloche S. (2007). Atypical mitogen-activated protein kinases: structure, regulation and functions. Biochim Biophys Acta. 1773, 1376-1387.

Coussens LM, Werb Z. (2002). Inflammation and cancer. Nature. 420, 860-867.

Cronauer MV, Schulz WA, Burchardt T, Ackermann R, Burchardt M. (2004). Inhibition of p53 function diminishes androgen receptor–mediated signaling in prostate cancer cell lines. Oncogene. 23, 3541–3549.

Cui Y, Kim DS, Park SH, Yoon JA, Kim SK, Kwon SB, Park KC. (2004). Involvement of ERK AND p38 MAP kinase in AAPH-induced COX-2 expression in HaCaT cells. Chem Phys Lipids. 129, 43-52.

Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. 2006. Clin Chem. 52, 601-623.

Daly H, Doyen JT, Purcell AH. (1998). Introduction to insect biology and diversity. 2nd

edition. Oxford University Press, New York, Chapter 14, 279-300.

Dar AA, Belkhiri A, Ecsedy J, Zaika A, El-Rifai W. (2008). Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells. Cancer Res. 68, 8998–9004.

186

Darnell JE Jr. (1997). STATs and gene regulation. Science. 277, 1630-1635.

Darzynkiewicz Z, Galkowski D, Zhao H (2008). Analysis of apoptosis by cytometry using TUNEL assay. Methods. 44: 250–254.

Dave S, Dkhar HK, Singh MP, Gupta G, Chandra V, Mahajan S, Gupta P. (2010). Hexafluoroisopropanol-induced helix-sheet transition of stem bromelain: correlation to function. Int J Biochem Cell Biol. 42, 938-947.

Davidovich IA, Levenson AS, Levenson Chernokhvostov VV. (2004). Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistance. Cancer Lett. 211, 189-197.

Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I. (2005). Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem. 95, 918-931.

Davis RJ. (2000). Signal transduction by the JNK group of MAP kinases. Cell. 103, 239–252.

de la Taille A, Rubin MA, Chen MW. (2003). Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells. Clin Cancer Res. 9, 1801-1807.

De Laurenzi V, Raschella G, Barcaroli D, Annicchiarico-Petruzzelli M, Ranalli M, Catani MV, Tanno B, Costanzo A, Levrero M, Melino G. (2000). Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J. Biol. Chem. 275, 15226–15231.

De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG. (2007). Inflammation in prostate carcinogenesis. Nat Rev Cancer. 7, 256-269.

Dedov VN, Tran VH, Duke CC, Connor M, Christie MJ, Mandadi S, Roufogalis BD. (2002). Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol. 137, 793–798.

Degenhardt Y., Lampkin T. (2010). Targeting Polo-like kinase in cancer therapy. Clin Cancer Res. 16, 384–389.

Denkert C, Köbel M, Berger S, Siegert A, Leclere A, Trefzer U, Hauptmann S.(2001). Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res.61, 303–308.

Dennis LK, Lynch CF, Sandler DP, Alavanja MCR. (2010). Pesticide Use and Cutaneous Melanoma in Pesticide Applicators in the Agricultural Heath Study. Environ. Health. Perspect.118, 812–817.

Dhalla NS, Temsah RM, Netticadan T. (2000). Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18, 655–673.

Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ. (1997). A cytoplasmic inhibitor of the JNK signal transduction pathway. Science. 277, 693-696.

Domico LM, Cooper KR, Bernard LP, Zeevalk GD. (2007). Reactive oxygen species generation by the ethylene-bisdithiocarbamate (EBDC) fungicide mancozeb and its contribution to neuronal toxicity in mesencephalic cells. Neurotoxicology. 28, 1079–1091.

Donato R. (1999). Functional roles of S100 proteins, calcium binding proteins of the EF-handtype. Biochim Biophys Acta. 145, 191-231.

Donato R. (2001). S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 33, 637–668.

Douglas WG, Tracy E, Tan D, Yu J, Hicks WL Jr, Rigual NR, Loree TR, Wang Y, Baumann H. (2004). Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness. Mol Cancer Res. 2, 585-593.

Doyle CE, Mackay JM, Ashby J. (1993). Failure of N-acetylcysteine to protect the mouse bone marrow against the clastogenicity of 7, 12-dimethylbenzanthracene. Mutagenesis. 8, 583-584.

Druker BJ, Guilhot F, O'Brien SG. (2006). Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 355, 2408-2417.

EBDC. (1998). EBDC Fact sheet. In: Pesticides News. No.39, pp. 20-21.

187

Ecke TH, Schlechte HH, Hübsch A, Lenk SV, Schiemenz K, Rudolph BD, Miller K. (2007). TP53 mutation in prostate needle biopsies--comparison with patients follow-up. Anticancer Res. 27, 4143-4148.

Eckerdt F, Yuan J, Strebhardt K. (2005). Polo-like kinases and oncogenesis. Oncogene. 24, 267-276.

Eddleston M, Karalliedde L, Buckley N, Fernando R, Hutchinson G, Isbister G, Konradsen F, Murray D, Piola JC, Senanayake N, Sheriff R, Singh S, Siwach SB, Smit L. (2002). Pesticide poisoning in the developing world—a minimum pesticides list. Lancet. 360, 1163-1167.

El Hamss R, Idaomar M, Alonso-Moraga A, Muñoz Serrano A. (2003). Antimutagenic properties of bell and black peppers. Food Chem Toxicol. 41, 41-47.

El-Deiry WS. (2003). The role of p53 in chemosensitivity and radiosensitivity. Oncogene. 22, 7486–7495.

El-Demerdash FM., Yousef MI., Al-Salhen KS. (2003). Protective effects of isoflavone on some biochemical parameters affected by cypermethrin in male rabbits. J Environ Sci Health B. 38, 365-378.

Ellis LM. (2004). Angiogenesis and its role in colorectal tumor and metastasis formation. Semin Oncol. 31, 3-9.

Emerlson Mose VJR. (2012). A Study on Challenges and Opportunities for Agricultural Development in India. IJPSS. 2, 318-332.

Engst R, Schnaak W. (1967). Metabolism of the fungicidal ethylenebis (dithiocarbamates), maneb and zineb: I. Identification and fungitoxic activity in a model experiment of synthesized metabolites. Z. Lebensm. Unters. Forsch. 134, 216–221.

Esposti DM, McLennan H. (1998). Mitochondria and cells produce reactive oxygen species in virtual anaerobiosis: relevance to ceramide-induced apaotosis. FEBS Lett. 430, 338-342.

Esquivel-Sentíes MS, Barrera I, Ortega A, Vega L. (2010). Organophosphorous pesticide metabolite (DEDTP) induces changes in the activation status of human lymphocytes by modulating the interleukin 2 receptor signal transduction pathway. Toxicol Appl Pharmacol. 248, 122-133.

Eum SY, Lee YW, Hennig B, Toborek M. (2006). Interplay between epidermal growth factor receptor and Janus kinase 3 regulates polychlorinated biphenyl-induced matrix metalloproteinase-3 expression and transendothelial migration of tumor cells. Mol Cancer Res. 4, 361-370.

Fan Y, Zhang YL, Wu Y. (2008). Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells. World J Gastroenterol. 14, 428-434.

Feng YB, Lin DC, Shi ZZ, Wang XC, Shen XM, Zhang Y, Du XL, Luo ML, Xu X, Han YL, Cai Y, Zhang ZQ, Zhan QM, Wang MR. (2009). Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of Survivin level in esophageal squamous cell carcinoma. Int. J. Cancer. 124, 578–588.

Ferris DK, Maloid SC, Li CC. (1998). Ubiquitination and proteasome mediated degradation of polo-like kinase. Biochem Biophys Res Commun. 252, 340-344.

Figueiredo ML, Kao C, Wu L. (2007). Advances in Preclinical Investigation of Prostate Cancer Gene Therapy. Mol Ther. 15, 1053–1064.

Filipek A, Jastrzebska B, Nowotny M, Kuznicki J. (2002). Cacy BP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J Biol Chem. 277, 28848– 52.

Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin AS Jr. (1997). Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem. 272, 24113-24116.

Fishbein L. (1976). Environmental health aspects of fungicides: I. Dithiocarbamtes. J Toxicol Environ Health. 1, 713–735.

Fishel FM. (2009). PI219: Pest Management and Pesticides: A Historical Perspective. Agronomy Department, Florida Cooperative Extension Service, Institute of Food and Agricultural Sciences, University of Florida. http://edis.ifas.ufl.edu.

188

Fishel FM. (2008). PI-64: Pesticide Toxicity Profile: Ethylenebis (dithiocarbamate) Pesticides. Pesticide Information Office, Florida Cooperative Extension Service. Institute of Food and Agricultural Sciences, University of Florida.

Fisher DE. (1994). Apoptosis in cancer therapy: crossing the threshold. Cell. 78, 539–542.

Fitsanakis VA, Amarnath V, Moore JT, Montine KS, Zhang J, Montine TJ. (2002). Catalysis of catechol oxidation by metal– dithiocarbamate complexes in pesticides. Free Radical Biol. Med. 33, 1714– 1723.

Flynn DL, Rafferty MF, Boctor AM. (1986). Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostaglandins Leukot Med. 24, 195-198.

Fodde R, Brabletz T. (2007). Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol.19, 150-158.

Fountaine TM, Wade-Martins R. (2007). RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport. J Neurosci Res. 85, 351-63.

Fresco P, Borges F, Diniz C, Marques MP. (2006). New insights on the anticancer properties of dietary polyphenols. Med Res Rev. 26, 747-766.

Fu GF, Lin XH, Han QW. (2005). RNA interference remarkably suppresses bcl-2 gene expression in cancer cells in vitro and in vivo. Cancer Biol Ther. 4: 822-829.

Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M. (2000). Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J Nutr. 130, 1124-1131.

Fukuda S, Pelus LM. (2006). Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther. 5, 1087–1098.

Fusenig NE, Boukamp P. (1994). Carcinogenesis studies in human cells: Reliable in vitro models, In: Cell Culture in Pharmaceutical Research. (Fusenig NE, Graf H., eds.). Berlin: Springer-Verlag Berlin Inc. 79–102.

Fusenig NE, Boukamp P. (1998). Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol. Carcinog. 23, 144–158.

Galcheva-Gargova Z, Derijard B, Wu IH, Davis RJ. (1994). An osmosensing signal transduction pathway in mammalian cells. Science 265, 806-808.

Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suarez A, Armas A. (1999). beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol. 155, 527-536.

Gao L, Zhang L, Hu J. (2005). Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Clin Cancer Res. 11, 6333-41.

Gatto NM, Rhodes SL, Manthripragada AD, Bronstein J, Cockburn M, Farrer M, Ritz B. (2010). α-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease. Neuroepidemiology. 35, 191-195.

Georgian L, Moraru I, Draghicescu T, Dinu I, Ghizelea G. (1983). Cytogenetic effects of alachlor and mancozeb. Mutat Res. 116, 341-348.

Geter DR, Chang LW, Hanley NM, Ross MK, Pegram RA, DeAngelo AB. (2004). Analysis of in vivo and in vitro DNA strand breaks from trihalomethane exposure. J Carcinog. 3, 2.

Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M. (2008). S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukoc. Biol. 83, 1484-1492.

Ghayur MN, Gilani AH. (2005). Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol. 45, 74–80.

189

Ghayur MN, Gilani AH, Afridi MB, Houghton PJ. (2005). Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascul Pharmacol. 43, 234–241.

Giglia-Mari G, Sarasin A. (2003). TP53 Mutations in Human Skin Cancers. Hum Mutat. 21, 217-228.

Gilden RC, Huffling K, Sattler B. (2010). Pesticides and health risks. J Obstet Gynecol Neonatal Nurs. 39, 103–110.

GLOBOCAN (IARC). (2008). Prostate Cancer. http://globocan.iarc.fr/factsheets/cancers/prostate.asp. Accessed May 1, 2011.

Golas JM, Lucas J, Etienne C. (2005). SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models. Cancer Res. 65, 5358-5364.

Goldstone SD, Fragonas JC, Jeitner TM, Hunt NH. (1995). Transcription factors as targets for oxidative signalling during lymphocyte activation. Biochim Biophys Acta. 1263, 114-122.

Golsteyn RM, Schultz SJ, Bartek J, Ziemiecki A, Ried T, Nigg EA. (1994). Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. J Cell Sci. 107, 1509-1517.

Gottmann E, Kramer S, Pfahringer B, Helma C. (2001). Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments. Environ Health Perspect. 109, 509-514.

Goulet AC, Einsphar JG, Alberts DS, Beas A, Burk C, Bhattacharyya A, Bangert J, Harmon JM, Fujiwara H, Koki A, Nelson MA. (2003). Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression. Cancer Biol Ther 2, 713–718.

Greenwald P. (2002). Cancer chemoprevention. BMJ. 324, 714-718.

Grzanna R, Lindmark L, Frondoza CG. (2005). Ginger--an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 8, 125-132.

Guan H, Zhou Z, Wang H, Jia SF, Liu W, Kleinerman ES. (2005a). A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Clin Cancer Res. 11, 2662-2669.

Guan R, Tapang P, Leverson JD, Albert D, Giranda VL, Luo Y. (2005b). Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals. Cancer Res. 65, 2698-2704.

Gullino M L, Tinivella F, Garibaldi A, Kemmitt GM, Bacci L, Sheppard B. (2010). Mancozeb: Past, Present, and Future. Plant disease. The American Phytopathological Society. 94, 1076-1087.

Gumireddy K, Reddy MV, Cosenza SC. (2005). ON01910, a non- ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell. 7, 275-286.

Guo WJ, Zeng MS, Yadav A, Song LB, Guo BH, Band V, Dimri GP. (2007). Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and downregulating Akt activity in breast cancer cells. Cancer Res. 67, 5083–5089.

Gupta KP, Mehrotra NK. (1992). Status of ornithine decarboxylase activity and DNA synthesis in mancozeb-exposed mouse skin. Carcinogenesis. 13, 131-133.

Gupta YK, Sharma M. (2001). Reversal of pyrogallol-induced delay in gastric emptying in rats by ginger (Zingiber officinale). Methods Find Exp Clin Pharmacol. 23, 501-513.

Gutman GM. (2009). Seniors’ Environmental Health Literature review. Health Canada, Healthy Environments and Consumer Safety, British Columbia Region, http://www.sfu.ca/uploads/page/04/GUTMANreport.pdf

Habig WH, Pabst MJ, Jakoby WB. (1974). Glutathione-S-transferases, the first enzymatic step in mercapturic acid formation. J Biol Chem. 249, 7130–7139.

Haddad JJ, Land SC. (2002). Redox/ROS regulation of lipopolysaccharide-induced mitogen activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis. Br J Pharmacol. 135, 520–536.

190

Hagmar L, Stromberg U, Tinnerberg H, Mikoczy Z. (2001). The usefulness of cytogenetic biomarkers as intermediate endpoints in carcinogenesis. Int J Hyg Environ Health. 204, 43–47.

Hajdu SI. (2011). A note from history: landmarks in history of cancer, part 2. Cancer. 117, 2811-2820.

Halvorsen EM, Dennis J, Keeney P, Sturgill TW, Tuttle JB, Bennett JB Jr. (2002). Methylpyridinium (MPP(+))- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells. Brain Res. 952, 98-110.

Hamanaka R, Maloid S, Smith MR, O'Connell CD, Longo DL, Ferris DK. (1994). Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase. Cell Growth Differ. 5, 249-257.

Hamasaki VK, Vokes EE. (1992). Chemotherapy in head and neck cancer. Curr Opin Oncol. 4, 1376–1384.

Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell. 100, 57-70.

Hande KR. (1998). Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer. 34, 1514–1521.

Handra-Luca A, Bilal H, Bertrand JC, Fouret P. (2003). Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation. Am J Pathol. 163,957–967.

Hannon GJ. (2002). RNA interference. Nature. 418, 244–251.

Haq R, Brenton J D, Takahashi M, Finan D, Finkielsztein A, Damaraju S, Rottapel R, Zanke B. (2002). Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res. 62, 5076-5082.

Hardas BD, Zhao X, Zhang J, Longqing X, Stoll S, Elder JT. (1996). Assignment of psoriasin to human chromosomal band 1q21: Coordinate overexpression of clustered genes in psoriasis. J Invest Dermatol. 106, 753–758.

Harms K, Nozell S, Chen X. (2004). The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci. 61, 822–842.

Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. (2002). Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist. 7, 492–508.

Hastak K, Alli E, Ford JM. (2010). Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin. Cancer Res. 70, 7970-7980.

Hayes JD, Pulford DJ. (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 30, 445–600.

Heidel JD, Yu Z, Liu JY. (2007). Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc Natl Acad Sci USA. 104, 5715-5721.

Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D. (2006). S100A8 and S100A9

activate MAP kinase and NF-B signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res. 312, 184 – 197.

Hertog MGL, Hollman PCH, Katan MB, Kromhout D. (1993). Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer. 20, 21–29.

Hoar SK, Blair A, Holmes FF, Boysen CD, Robel RJ, Hoover R, Fraumeni JF Jr. (1986). Agricultural herbicide use and risk of lymphoma and soft-tissue carcoma. JAMA. 256, 1141-1147.

Hsu CH, Chan D, Greggio E, Saha S, Guillily MD, Ferree A, Raghavan K, Shen GC, Segal L, Ryu H, Cookson MR, Wolozin B. (2010). MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2. J Neurochem. 112, 1593-1604.

http://www.cibrc.nic.in/cibrc.htm

191

http://www.fda.gov/cder/drug/infopage/cox2/NSAIDdecisionMemo.pdf

http://www.fda.gov/cder/foi/appletter/1998/17970s40.pdf

http://flyembryo.nhlbi.nih.gov/images/mechanismRNAi.png

Huang C, Ma WY, Li J, Goranson A, Dong Z. (1999). Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J Biol Chem. 274, 14595-14601.

Huang C, Ma WY, Young MR, Colburn N, Dong Z. (1998). Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci U S A. 95, 156-161.

IARC (International Agency for Research on Cancer). (2008). Lyon, France: IARC Press. World Cancer Report. 9–510. Available: http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/index.php

IARC Working Group. (1991). Occupational exposures in spraying and application of insecticides. IARC Monogr Eval Carcinog Risks Hum. 53, 45-92.

IARC/NCI/EPA Working Group. (1985). Cellular and Molecular mechanisms of cell transformation and standardization of transformation assays of established cell lines for the prediction of carcinogenic chemicals: Overview and recommended protocols. Cancer Res. 45, 2395-2399.

Ikezoe T, Yang J, Nishioka C, Takezaki Y, Tasaka T, Togitani K, Koeffler HP, Yokoyama A. (2009). A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies. Leukemia. 23, 1564-1576.

Inbaraj JJ, Chignell CF. (2004). Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. Chem Res Toxicol. 17, 55-62.

Ioffe ML, White E, Nelson DA, Dvorzhinski D, DiPaola RS. (2004). Epothilone-induced cytotoxicity is dependent on p53 status in prostate cells. Prostate. 61, 243-247.

Iqbal J., Neppalli VT., Wright G. (2006). BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J Clin Oncol. 24, 961-968.

Irwin MS, Kaelin WG. (2001). p53 family update: p73 and p63 develop their own identities. Cell Growth Differ. 12, 337-349.

Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin WG Jr. (2003). Chemosensitivity linked to p73 function. Cancer Cell. 3, 403-410.

Irwin MS. (2004). Family feud in chemosensitvity: p73 and mutant p53. Cell Cycle. 3, 319-323.

Isa Y, Miyakawa Y, Yanagisawa M, Goto T, Kang MS, Kawada T, Morimitsu Y, Kubota K, Tsuda T. (2008). 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 373, 429-434.

Ishiguro K, Ando T, Maeda O, Ohmiya N, Niwa Y, Kadomatsu K, Goto H. (2007). Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms. Biochem Biophys Res Commun. 362, 218-223.

Ishii Y, Ikushima T. (2002). Post-treatment effects of DNA topoisomerase inhibitors on UVB- and X-ray-induced chromosomal aberration formations. Mutat Res. 25, 67-74.

Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J. (2008). ROS generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 320, 661–664.

Jablonicka A, Polakova H, Karelova J, Vargova M. (1989). Analysis of chromosome aberrations and sister-chromatid exchanges in peripheral blood lymphocytes of workers with occupational exposure to the mancozeb-containing fungicide Novozir Mn80. Mutat Res. 224, 143-146.

Jang YJ, Ma S, Terada Y, Erikson RL. (2002). Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase. J Biol Chem. 277, 44115-44120.

Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. (2005) Cancer statistics. CA Cancer J Clin. 55, 10-30.

192

Jenner P. (2003). Oxidative stress in Parkinson's disease. Ann Neurol. 53 Suppl 3, S26-36.

Jimeno A, Rubio-Viqueira B, Rajeshkumar NV, Chan A, Solomon A, Hidalgo M. (2010). A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer. Mol Cancer Ther. 9, 311–318.

Johnstone RW, Ruefli AA, Lowe SW. (2002). Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108, 153-164.

Joo JH, Kim JW, Lee Y, Yoon SY, Kim JH, Paik SG, Choe IS. (2003). Involvement of NF-kB in the regulation of S100A6 gene expression in human hepatoblastoma cell line HepG2. Biochem Biophys Res Commun. 307, 274-280.

Jordan MA, Wilson L. (2004). Microtubules as a target for anticancer drugs. Nat Rev Cancer. 4, 253-265.

Judge AD, Robbins M, Tavakoli I. (2009). Confirming the RNAi mediated mechanism of action of siRNA-based cancer therapeutics in mice. J Clin Invest. 119, 661-673.

Junqueira VBC, Simizu K, Videla LA, Barros SBM. (1986). Dose-dependent study of the effects of acute lindane administration on rat liver superoxide anion production, antioxidant enzyme activities and lipid peroxidation. Toxicology. 41, 193-204.

Jurewicz J, Hanke W. (2008). Prenatal and childhood exposure to pesticides and neurobehavioral development: review of epidemiological studies. Int J Occup Med Environ Health. 21, 121–132.

Kaars Sijpesteijn A. (1982). Mechanism of action of fungicides. In: Fungicide Resistance in Crop Plants. (Dekker J, Georgopoulos SG eds.). Wageningen, the Netherlands. 32- 45.

Kaars Sijpesteijn A. (1984). Mode of action of some traditional fungicides. In: Mode of Action of Antifungal Agents. (Trinci APJ, Ryley JF. Eds.)Cambridge University Press, Cambridge. 135-153

Kackar R, Srivastava MK, Raizada RB. (1997). Studies on rat thyroid after oral administration of Mancozeb: morphological and biochemical evaluations. J Appl Toxicol. 17, 369-375.

Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A. (1997). Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90, 809-819.

Kakkar P, Das B, Viswanathan PN. (1984). A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 21, 130-132.

Kalender S, Kalender Y, Ogutcu A, Uzunhisarcikli M, Durak D, Aηikgoz F. (2004). Endosulfan-induced cardiotoxicity and free radical metabolism in rats: the protective effect of vitamin E. Toxicology. 202, 227-235.

Kalivendi SV, Cunningham S, Kotamraju S, Joseph J, Hillard CJ, Kalyanaraman B. (2004). Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide. J Biol Chem. 279, 15240-15247.

Kalra N, Bhui K, Roy P, Srivastava S, George J, Prasad S, Shukla Y. (2008). Regulation of p53, nuclear factor kappaB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin. Toxicol Appl Pharmacol. 226, 30-37.

Kamihira S, Yamada Y, Hirakata Y. (2001). Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis. Br J Haematol. 114, 63-69.

Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, Christensen R, Han T, Park NH. (2007). Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer. 96, 126–133.

Kantarjian H, Giles F, Wunderle L. (2006). Nilotinib in imatinibresistant CML and Philadelphia chromosome-positive ALL. N Engl J Med. 354, 2542-2551.

Kanter PM, Schwartz A. (1979). A hydroxyapatite batch assay for quantitation of cellular DNA damage. Anal Biochem. 97, 77–84.

Karin M, Cao Y, Greten FR, Li ZW. (2002). NF-kB in cancer: from innocent bystander to major culprit, Nature Rev. Cancer 2 301–310.

193

Karpinich NO, Tafani M, Rothman RJ, Russo MA, Farber JL. (2002). The Course of Etoposide-induced Apoptosis from Damage to DNA and p53 Activation to Mitochondrial Release of Cytochrome c. J Biol Chem. 277,16547–16552.

Kastan MB, Bartek J. (2004). Cell-cycle checkpoints and cancer. Nature. 432, 316–323.

Kuruganti K, Sudhakar (2005). “Killing and Poisoning Pests or Human Beings? – acute poisoning of pesticide users through pesticide exposure/inhalation” : Centre for Sustainable Agriculture.

Kawabe T. (2004). G2 checkpoint abrogators as anticancer drugs. Mol Cancer Ther. 3, 513–519.

Kawai M, Saegusa Y, Dewa Y, Nishimura J, Kemmochi S, Harada T, Ishii Y, Umemura T, Shibutani M, Mitsumori K. (2010). Elevation of cell proliferation via generation of reactive oxygen species by piperonyl butoxide contributes to its liver tumor-promoting effects in mice. Arch Toxicol. 84, 155-164.

Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. (1998). Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58, 5071-5074.

Kawata E, Ashihara E, Kimura S. (2008). Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer. Mol Cancer Ther. 7, 2904-2912.

Kee SH, Jang SI, Ahvazi B, Larsen M, Yamada KM, Steinert PM. 2002. Cell-cell adhesion and RhoA-mediated actin polymerization are independent phenomena in microtubule disrupted keratinocytes. J Invest Dermatol. 119, 440-448.

Kegley SE, Hill BR, Orme S, Choi AH. (2011). PAN Pesticide Database, Pesticide Action Network North America, San Francisco, CA, http:www.pesticideinfo.org.

Kesavachandran CN, Fareed M, Pathak MK, Bihari V, Mathur N, Srivastava AK. (2009). Adverse Health Effects of pesticides in Agrarian Populations of Developing Countries. Reviews of Environmental Contamination and Toxicology, 200, 33-52.

Keyes WM, Wu Y, Vogel H, Guo X, Lowe SW, Mills AA. (2005). p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev. 19, 1986–1999.

Khan PK, Sinha SP. (1994). Impact of higher doses of vitamin C in modulating pesticide genotoxicity. Teratog Carcinog Mutagen. 14, 175 – 181.

Khan SM, Sobti RC, Kataria L. (2005). Pesticide-induced alteration in mice hepato-oxidative status and protective effects of black tea extract. Clin Chim Acta. 358, 131-138.

Khan TH, Prasad L, Anuradha, Sultana S. (2005). Soy isoflavones inhibits the genotoxicity of benzo(a)pyrene in Swiss albino mice. Hum Exp Toxicol. 24, 149-155.

Kilanczyk E, Filipek S, Jastrzebska B, Filipek A. (2009). CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1, Biochem Biophys Res Commun. 380, 54–59.

Kim JK, Diehl JA. (2009). Nuclear cyclin D1: An oncogenic driver in human cancer. 2009. J Cell Physiol. 220, 292–296.

Kim JK, Kim Y, Na KM, Surh YJ, Kim TY. (2007). [6]-Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Radic Res. 41, 603-614.

Kim JY, Oh KN, Han EH, Kim DH, Jeong TC, Lee ES, Jeong HG. (2005). Methoxychlor-induced inducible nitric oxide synthase and proinflammatory cytokines expression in macrophages via NF-kappaB, ERK, and p38 mitogen-activated protein kinases. Biochem Biophys Res Commun. 333,1234-1240.

Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC. (2003). Survivin and molecular pathogenesis of colorectal cancer. Lancet. 362, 205–209.

Kim SA, Kwon SM, Yoon JH, Ahn SG. (2010). The antitumor effect of PLK1 and HSF1 double knockdown on human oral carcinoma cells. Int J Oncol. 36, 867–872.

Kim SO, Kundu JK, Shin YK, Park JH, Cho MH, Kim TY, Surh YJ. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene. 24, 2558-2567.

194

Kimura S, Ashihara E, Maekawa T. (2006). New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. Curr Pharm Biotechnol. 7, 371-379.

Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. (1992). Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull (Tokyo). 40, 387-391.

Kiuchi F, Shibuya M, Sankawa U. (1982). Inhibitors of prostaglandin biosynthesis from ginger. Chem Pharm Bull (Tokyo). 30, 754-757.

Klaunig JE., Kamendulis LM., Hocevar BA. Oxidative Stress and Oxidative Damage in Carcinogenesis. 2010. Toxicol Pathol. 38, 96-109.

Koida N, Ozaki T, Yamamoto H, Ono S, Koda T, Ando K. (2008). Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation. J Biol Chem. 283, 8555–8563.

Koldehoff M, Steckel NK, Beelen DW, Elmaagacli AH. (2007). Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia. Clin Exp Med. 7, 47-55.

Konnikova L, Simeone MC, Kruger MM, Kotecki M, Cochran BH. (2005). Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Cancer Res. 65, 6516-6520.

Krajewska M, Krajewski S, Banares S, Huang X, Turner B, Bubendorf L, Kallioniemi OP. (2003). Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res. 9, 4914–4925.

Kross BC, Burmeister LF, Ogilvie LK, Fuortes LJ, Fu CM. (1996). Proportionate mortality study of golf course superintendents. Am J Ind Med. 29, 501-506.

Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK. (2008). Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 68, 1777–1785.

Kyriakis JM, Avruch J. (2001).Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 81, 807–869.

Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160.

Lake RJ, Jelinek WR. (1993). Cell cycle- and terminal differentiation associated regulation of the mouse mRNA encoding a conserved mitotic protein kinase. Mol Cell Biol. 13, 7793-7801.

Lam RY, Woo AY, Leung PS, Cheng CH. (2007). Antioxidant actions of phenolic compounds found in dietary plants on low-density lipoprotein and erythrocytes in vitro. J Am Coll Nutr. 26, 233-242.

Lampe JW. (2003). Spicing up a vegetarian diet: chemopreventive effects of phytochemicals. Am. J. Clin. Nutr. 78, 579S-583S.

Langner E, Greifenberg S, Gruenwald J. (1998). Ginger: history and use. Adv Ther.15, 25-44.

Lansing TJ, McConnell RT, Duckett DR, Spehar GM, Knick VB, Hassler DF. (2007). In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1. Mol Cancer Ther. 6, 450–459.

Lantz RC, Chen GJ, Sarihan M, Sólyom AM, Jolad SD, Timmermann BN. (2007). The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine. 14, 123-128.

Lassi K, Dawson NA. (2009). Emerging therapies in castrate-resistant prostate cancer. Curr Opin Oncol. 21, 260-265.

Lauwers GY, Scott GV, Karpeh MS. (1995). Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer. 75, 2209-2213.

Laverge H, Van der Elst J, De Sutter P, Verschraegen-Spae MR, De Paepe A, Dhont M. (1998). Fluorescent in-situ hybridization on human embryos showing cleavage arrest after freezing and thawing. Human Reprod. 13, 425-429.

195

Leader A, Kemmitt G, Orpin C. (2008). Dithane keeping an old friend going! Proc. Euroblight Workshop, Hamar, Norway.

Ledirac N, Antherieu S, Dupuy d’Uby A, Caron JC, Rahmani R. (2005). Effects of organochlorine insecticides on MAP kinase pathways in human HaCaT keratinocytes: key kole of reactive oxygen species. Toxicol Sci. 86, 444–452.

Lee HS, Seo EY, Kang NE, Kim WK. (2008a). [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem. 19, 313-319.

Lee KS, Yuan YL, Kuriyama R, Erikson RL. (1995). Plk is an M-phase specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1. Mol Cell Biol. 15, 7143-51.

Lee LM, Pan CC, Cheng CJ (2001). Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia. Anticancer Res. 21: 1291–1294.

Lee SH, Cekanova M, Baek SJ. (2008b). Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog. 47, 197-208.

Leiphon LJ, Picklo MJ Sr. (2007). Inhibition of aldehyde detoxification in CNS mitochondria by fungicides. Neurotoxicology. 28, 143-149.

Leslie EM, Deeley RG, Cole SP. (2001). Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology. 167, 3-23.

Levine AJ. (1997). p53, the cellular gatekeeper for growth and division. Cell. 88, 323–331.

Li F, Ling X. (2006). Survivin study: an update of ‘what is the next wave’? J Cell Physiol. 208, 476–486.

Li H, Wang Y, Liu X. (2008). Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression. J Biol Chem. 283, 6209-6221.

Li MJ, McMahon R, Snyder DS, Yee JK, Rossi JJ. (2003). Specific killing of Ph+ chronic myeloid leukemia cells by a lentiviral vectordelivered anti-bcr/abl small hairpin RNA. Oligonucleotides. 13, 401-409.

Lim SY, Raftery MJ, Goyette J, Hsu K, Geczy CL. (2009). Oxidative modifications of S100 proteins: functional regulation by redox. J Leukoc Biol.86. 577–587.

Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. (2003). Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol. 21, 631–637.

Lindh CH, Littorin M, Johannesson G, Jönsson BAG. (2008). Analysis of Ethylenethiourea as a Biomarker in Human Urine using Liquid Chromatography/triple Quadrupole Mass Spectrometry. Rapid Commun Mass Spectrom. 22, 2573-2579.

Lindon C.0, Pines J. (2004). Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells. J Cell Biol. 164, 233-241.

Ling X, Arlinghaus RB. (2005). Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Res. 65, 2532-2536.

Liu J, Li Q, Yang X, van Breemen RB, Bolton JL, Thatcher GR. (2005). Analysis of protein covalent modification by xenobiotics using a covert oxidatively activated tag: raloxifene proof-of-principle study. Chem Res Toxicol. 18, 1485-1496.

Liu L, Andrews LG, Tollefsbol TO. (2006a). Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death. Oncogene. 25, 4370–4375.

Liu S, Yamauchi H. (2010). Etoposide induces growth arrest and disrupts androgen receptor signaling in prostate cancer cells. Oncol Rep. 23,165-170.

Liu W, Reinmuth N, Stoeltzing O, Parikh AA, Tellez C, Williams S. (2003). Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways. Cancer Res. 63, 3632–3636.

Liu W, Reinmuth N, Stoeltzing O. (2002). Antiangiogenic therapy targeting factors that enhance endothelial cell survival. Semin Oncol. 29, 96-103.

196

Liu X, Erikson RL. (2003). Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA. 100, 5789- 5794.

Liu X, Lei M, Erikson RL. (2006b). Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol Cell Biol. 26, 2093-20108.

Lobe J. “WHO urges DDT for malaria control strategies”. 2006. Inter Press Service, cited from commondreams.org.

Loercher A, Lee TL, Ricker JL, Howard A, Geoghegen J, Chen Z, Sunwoo JB, Sitcheran R, Chuang EY, Mitchell JB, Baldwin AS Jr, Van Waes C. (2004). Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res 64, 6511–6523.

Lokshin M, Tanaka T, Prives C. (2005). Transcriptional regulation by p53 and p73. Cold Spring Harb Symp Quant Biol. 70, 121–128.

Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T. (1994). p53 status and the efficacy of cancer therapy in vivo. Science. 266, 807–810.

Lowe SW, Ruley HE, Jacks T, Housman DE. (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74, 957-967.

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with Folin phenol reagent. J Biol Chem. 193, 265-275.

Lu QL, Elia G, Lucas S, Thomas JA. (1993). Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer. 53, 29-35.

Ludwig RD, Thorn GD. (1960). Chemistry and mode of action of Dithiocarbamate fungicides. Adv. Pest Control Res. 30, 219-252.

Lyons G and Watterson A. (2010). A Review of the Role Pesticides Play in Some Cancers: Children, Farmers and Pesticide Users at Risk?. Chemtrust, London.

Mader RM, Müller M, Steger GG. (1998). Resistance to 5-fluorouracil. Gen Pharmacol. 31, 661–666.

Maelandsmo GM, Florenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O. (1997) Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer. 74, 464–469

Mahadevaswami MP, Jadaramkunti UC, Hiremath MB, Kaliwal BB. (1999). Effect of Mancozeb on Ovarian Compensatory Hypertrophy and Biochemical Constituents in Hemicastrated Albino Rat. Reprod Toxicol. 14, 127-134.

Mahon FX, Belloc F, Lagarde V. (2003). MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models. Blood. 101, 2368-2373.

Mandell JW, Hussaini IM, Zecevic M, Weber MJ, VandenBerg SR. (1998). In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. Am J Pathol. 153, 1411–1423.

Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG. (1994). Transformation of mammalian cells by constitutively active MAP kinase kinase. Science. 265, 966–970.

Mantovani A. (2005). Cancer: inflammation by remote control. Nature. 435, 752–753.

Markovic J, Borras Blasco C, Ortega A, Pallardo F, Vina Ribes J (2005). Cellular Distribution of Reduced Glutathione During Cell Cycle in 3T3 Fibroblasts. J. Physiol. 565P, PC160.

Maronpot RR. (1999). Chemical Carcinogenesis. In: Handbook of Toxicologic Pathology, (W Haschek and CG Rousseaux eds). Academic Press, San Diego, California, 91-129.

Martinez JD, Craven MT, Joseloff E, Milczarek G, Bowden GT. (1997). Regulation of DNA binding and transactivation in p53 by nuclear localization and phosphorylation. Oncogene. 14, 2511–2520.

197

Marzouk MS, Soliman FM, Shehata IA, Rabee M, Fawzy GA. (2007). Flavonoids and biological activities of Jussiaea repens. Nat Prod Res. 21, 436-443.

Masuda M, Suzui M, Yasumatu R. (2002). Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res. 62, 3351-3355.

Mateuca R, Lombaert N, Aka PV, Decordier I, Kirsch-Volders M. (2006). Chromosomal changes: induction, detection methods and applicability in human biomonitoring. Biochimie. 88, 1515-1531.

Matthess Y, Kappel S, Spa¨nkuch B, Zimmer B, Kaufmann M, Strebhardt K. (2005). Conditional inhibition of cancer cell proliferation by tetracycline-responsive. H1 promoter-driven silencing of PLK1. Oncogene. 24, 2973–2980.

McCauley LA, Anger WK, Keifer M, Langley R, Robson MG, Rohlman D. (2006). Studying health outcomes in farmworker populations exposed to pesticides. Environ Health Perspect. 114(3), 953–960.

McDonnell TJ, Korsmeyer SJ. (1991). Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature. 349, 254-256.

McDonnell TJ, Troncoso P, Brisbay SM. (1992). Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52, 6940-6944.

McEleny KR, Watson RW, Coffey RN, O’Neill AJ, Fitzpatrick JM. (2002). Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate. 51, 133–140.

McGill G, Fisher DE. (1999). p53 and cancer therapy: a double-edged sword. J Clin Invest. 104, 223–225.

McGrogan BT, Gilmartin B, Carney DN, McCann A. (2008). Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta. 1785, 96-132.

McKeage K, Keam SJ. (2005). Docetaxel in hormone-refractory metastatic prostate cancer. Drugs. 65, 2287-2294.

Mehrotra NK, Kumar S, Shukla Y. (1987). Tumour initiating activity of mancozeb — a carbamate fungicide in mouse skin. Cancer Lett. 36, 283-287.

Melino G, De Laurenzi V, Vousden KH. (2002). p73: Friend or foe in tumorigenesis. Nat Rev Cancer. 2, 605-615.

Melino G, Bernassola F, Ranalli M, Yee K, Zong WX, Corazzari M, Knight RA, Green DR, Thompson C, Vousden KH. (2004). p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem. 279, 8076–8083.

Meyer AL. (1983). In vitro transformation assays for chemical carcinogens. Mutat Res. 115, 323-338.

Mikkola M. (2007). P63 in Skin Appendage Development. Cell Cycle. 6, 285–290.

Miller GT. (2002). Living in the environment. 12th Ed., Belmont: Wadsworth/Thomson Learning.

ISBN 0-534-37697-5.

Miller GT. (2004). Sustaining the Earth. 6th edition. Thompson Learning, Inc. Pacific Grove,

California. Chapter 9, 211-216.

Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. (1999). P63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 398, 708–713.

Mills PK, Yang R, Riordan D. (2005). Lymphohematopoietic cancers in the United Farm Workers of America (UFW), 1988–2001. Cancer Causes Control. 16, 823–830.

Mizumoto K, Rothman RJ, Farber JL. (1994). Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide. Mol. Pharmacol. 46, 890–895.

Mizuno H, Cho YY, Ma WY, Bode AM, Dong Z. (2006). Effects of MAP kinase inhibitors on epidermal growth factor- induced neoplastic transformation of human keratinocytes. Mol. Carcinog. 45, 1-9.

198

Monis B, Valentich MA. (1993). Promoting effects of mancozeb on pancreas of nitrosomethylurea treated rats. Carcinogenesis. 14, 929-933.

Monzo M, Rosell R, Felip E. (1999). A novel anti-apoptosis gene: Reexpression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol. 17, 2100-2104.

Mross K, Frost A, Steinbild S, Hedbom S, Rentschler J, Kaiser R. (2008). Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors. J Clin Oncol. 26, 5511–5517.

Muguruma M, Nishimura J, Jin M, Kashida Y, Moto M, Takahashi M, Yokouchi Y, Mitsumori K. (2006). Molecular pathological analysis for determining the possible mechanism of piperonyl butoxide-induced hepatocarcinogenesis in mice. Toxicology. 228, 178-187.

Muguruma M, Unami A, Kanki M, Kuroiwa Y, Nishimura J, Dewa Y, Umemura T, Oishi Y, Mitsumori K. (2007). Possible involvement of oxidative stress in piperonyl butoxide induced hepatocarcinogenesis in rats. Toxicology. 236, 61-75.

Harliansyah, Murad NA, Ngah WZW, Yusof YAM. (2007). Antiproliferative, antioxidant and apoptosis effects of Zingiber officinale and 6-Gingerol on HepG2 cells. Asian. J. Biochem. 2, 421-426.

Murphy G. (2005). Resistance Management- Pesticide Rotation. Ontario Ministry of Agriculture, Food and Rural affairs.

Nahta R, Takahashi T, Ueno NT, Hung MC, Esteva FJ. (2004). P27(kip1) down-regulation is associated with trastuzumab resistance in breast cancer cells. Cancer Res. 64, 3981-3986.

Nam NH, Parang K. (2003). Current targets for anticancer drug discovery. Curr Drug Targets. 4, 159–179.

NCI. (2004). National Cancer Institute. Cancer and the environment: what you need to know, what you can do. U.S. Department of Health and Human Services. Accessed at http://www.nci.nih.gov/newscenter/benchmarks-vol4-issue3

Németh J, Stein I, Haag D, Riehl A, Longerich T, Horwitz E, Breuhahn K, Gebhardt C, Schirmacher P, Hahn M, Ben-Neriah Y, Pikarsky E, Angel P, Hess J. (2009). S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology. 50, 1251-1262.

Nersesyan A, Muradyan R, Kundi M, Knasmueller S. (2011). Impact of smoking on the frequencies of micronuclei and other nuclear abnormalities in exfoliated oral cells: a comparative study with different cigarette types. Mutagenesis. 26, 295-301.

Nigam N, Prasad S, Shukla Y (2007). Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin. Food Chem Toxicol. 45, 2331–2335.

Nigam N, Bhui K, Prasad S, George J, Shukla Y. (2009a). [6]-Gingerol induces reactive oxygen species regulated mitochondrial cell death pathway in human epidermoid carcinoma A431 cells. Chem Biol Interact. 181, 77-84.

Nigam N, George J, Shukla Y. (2009b). Ginger ([6]-Gingerol). In: Molecular targets and therapeutic uses of spices- Modern Uses for Ancient Medicine. (Aggrawal BB, Kunnumakkara eds.). World Scientific Publishing Co. Pte. Ltd. Singapore. 225-256.

Nigam N, George J, Srivastava S, Roy P, Bhui K, Singh M, Shukla Y. (2010). Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a]P-induced mouse skin tumorigenesis. Cancer Chemother Pharmacol. 65, 687-696.

Nogawa M, Yuasa T, Kimura S. (2005). Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. J Clin Invest. 115, 978-985.

Nohmi T, Kim SR, Yamada M. (2005). Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes. Mutat Res. 591, 60-73.

199

Nowotny M, Spiechowicz M, Jastrzebska B, Filipek A, Kitagawa K, Kuznicki J. (2003). Calcium-regulated interaction of Sgt1 with S100A6 (calcyclin) and other S100 proteins. J Biol Chem 278, 26923–26928.

Nusse M, Beisker W, Kramer J, Miller BM, Schreiber GA. (1994). Measurement of micronuclei by flow cytometry, Methods. Cell. Biol. 42, 149–158.

O'Brien SG, Guilhot F, Larson RA. (2003). Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronicphase chronic myeloid leukemia. N Engl J Med. 348, 994-1004.

Oguri T, Ozasa H, Uemura T. (2008). MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer. Mol Cancer Ther. 7, 1150-1155.

Ohkawa H, Ohisi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbutric acid reaction. Anal Biochem. 95, 351–358.

Orre LM, Pernemalm M, Lengqvist J, Lewensohn R, Lehtiö J. (2007). Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling. Mol Cell Proteomics. 6, 2122-2131.

Orsi L, Delabre L, Monnereau A, Delval P, Berthou C, Fenaux P, Marit G, Soubeyran P, Huguet F, Milpied N, Leporrier M, Hemon D, Troussard X, Clavel J. (2009). Occupational exposure to pesticides and lymphoid neoplasms among men: results of a French case-control study. Occup Environ Med. 66, 291-298.

Ouyang W, Luo W, Zhang D, Jian J, Ma Q, Li J, Shi X, Chen J, Gao J, Huang C. (2008). PI-3K/Akt Pathway-Dependent Cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation. Environ Health Perspect. 116, 1-6.

Ozaki T, Nakagawara A. (2005). p73, a sophisticated p53 family member in the cancer world. Cancer Sci. 96, 729–737.

Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G. (2003). Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. Ceitalic J Clin Oncol/ceitalic. 21, 927–931.

PAN. (2009). Pesticide Action Network. International list of Highly Hazardous Pesticides.

Panganiban L, Cortes-Maramba N, Dioquino C, Lurenda Suplido M, Ho H, Francisco-Rivera A, Manglicmot-Yabes A. (2004).Correlation between Blood Ethylenethioures and Thyroid Gland Disorders among Banana Plantation Workers in Philippines. Environ Health Perspect. 112, 42-45.

Park YJ, Wen J, Bang S, Park SW, Song SY. (2006). [6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med J. 47, 688-697.

Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global Cancer Statistics 2002. CA Cancer J Clin. 55, 74-108.

Peek Jr RM, Crabtree JE. (2006). Helicobacter infection and gastric neoplasia. J Pathol, 208, 233–248.

Pepper C, Bentley P, Hoy T. (1996). Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia. Br J Haematol. 95, 513-517.

Pezzella F, Turley H, Kuzu I. (1993). bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med. 329, 690-694.

Prasad S, Kalra N, Shukla Y. (2007). Hepatoprotective effects of lupeol and mango pulp extract of carcinogen induced alteration in Swiss albino mice. Mol Nutr Food Res. 5, 352-359.

Prasanthi K, Muralidhara, Rajini PS. (2005). Fenvalerate-induced oxidative damage in rat tissues and its attenuation by dietary sesame oil. Food Chem Toxicol. 43, 299-306.

Preston RJ, Dean BJ, Galloway S, Holden H, McFee AF. (1987). Shelby M. Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells. Mutat Res. 189, 157-165.

Priebsch A., Rompe F., Tonnies H. Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cells. 2006. Oligonucleotides. 16, 263-74.

200

Qin L, Zhang X, Zhang L, Feng Y, Weng GX, Li MZ, Kong QL, Qian CN, Zeng YX, Zeng MS, Liao DF, Song LB. (2008). Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 371, 531–535.

Rabilloud T, Vuillard L, Gilly C, Lawrence JJ. (1994). Silver-staining of proteins in polyacrylamide gels: a general overview, Cell Mol. Biol. (Noisyle-grand) 40, 57–75.

Raitano AB, Halpern JR, Hambuch TM, Sawyers CL. (1995). The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc Natl Acad Sci U S A. 92, 11746–11750.

Ramos RR, Cebrian EM, E. Garrido. (2005). Benzoquinone activates the ERK/MAPK signaling pathway via ROS production in HL-60 cells. Toxicology. 209, 279–287.

Read AP, Strachan T. (1999). Chapter 18: Cancer Genetics. In: Human molecular genetics 2. New York. Wiley.

Reagan-Shaw S, Ahmad N. (2005). Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer. FASEB J. 19, 611-613.

Ren Q, Kari C, Quadros MR, Burd R, McCue P, Dicker AP, Rodeck U. (2006). Malignant Transformation of Immortalized HaCaT Keratinocytes through Deregulated Nuclear Factor KB Signaling. Cancer Res. 66, 5209-5215.

Ren R, Wang T, Jiang N, Liu T, Du Y, Li C, Zhang L, Fu F. (2010). Protective effects of Danshensu on liver injury induced by omethoate in rats. Toxicol Mech Methods. 20, 510-514.

Rennefahrt UE, Illert B, Kerkhoff E, Troppmair J, Rapp UR. (2002). Constitutive JNK activation in NIH 3T3 fibroblasts induces a partially transformed phenotype. J Biol Chem. 277, 29510–29518.

Rennefahrt U, Janakiraman M, Ollinger R, Troppmair J. (2005). Stress kinase signaling in cancer: fact or fiction? Cancer Lett. 217, 1-9.

Renner AG, Dos Santos C, Recher C. (2009). Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cells. Blood. 114, 659-662.

Renyi-Vamos F, Tovari J, Fillinger J. (2005). Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res. 11, 7344-7353.

Reuben SH. (2010). Reducing Environmental Cancer Risk: What We Can Do Now: 2008-2009 Annual Report. President's Cancer Panel Bethesda, MD: National Cancer Institute.

Rodel F, Hoffmann J, Distel L. (2005). Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res. 65, 4881-4887.

Rodrigues GA, Park M, Schlessinger J. (1997). Activation of the JNK pathway is essential for transformation by the Met oncogene. Embo J. 16, 2634–2645.

Rossi G, Buccione R, Baldassarre M, Macchiarelli G, Grazia Palmerini M, Cecconi S. (2006). Mancozeb Exposure in Vivo Impairs Mouse Oocyte Fertilizability. Reprod Toxicol. 21, 216–219.

Rowinsky EK. (1997). The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med. 48, 353–374.

Rydberg B. (1975). The rate of strand separation in alkali and DNA of irradiated mammalian cells. Radiat Res. 61, 274-287.

Sah NK, Khan Z, Khan GJ, Bisen PS. (2006). Structural, functional and therapeutic biology of surviving. Cancer Lett. 244, 164 – 171.

Saifudeen Z, Diavolitsis V, Stefkova J, Dipp S, Fan H, El-Dahr SS. (2005). Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression. J Biol Chem. 280, 23094–23102.

Saito F, Yokota H, Sudo Y, Yakabe Y, Takeyama H, Matsunaga T. (2006). Application of RNAi inducible TNFRI knockdown cells to the analysis of TNFalpha-induced cytotoxicity. Toxicol In Vitro. 20, 1343-1353.

201

Sakr SA. (2007). Ameliorative Effect of Ginger (Zingiber officinale ) on Mancozeb Fungicide Induced Liver Injury in Albino Rats. Aust. J. Basic Appl. Sci. 1, 650-656,

Salama I, Malone PS, Mihaimeed F, Jones JL. (2008). A review of the S100 proteins in cancer. Eur J Surg Oncol. 34, 357-64.

Sanborn M, Kerr KJ, Sanin LH, Cole DC, Bassil KL, Vakil C. (2007). Non-cancer health effects of pesticides: systematic review and implications for family doctors. Can Fam Physician. 53, 1712–1720.

Savoia P, Fava P, Nardò T, Osella-Abate S, Quaglino P, Bernengo MG. (2009). Skin metastases of malignant melanoma: a clinical and prognostic survey. Melanoma Res. 19, 321-326.

Sawyers CL. (1999). Chronic myeloid leukemia. N Engl J Med. 340, 1330-1340.

Sawyers CL, Hochhaus A, Feldman E. (2002). Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood. 99, 3530-3539.

Sayre LM, Smith MA, Perry G. (2001). Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem. 8, 721–738.

Scherr M, Battmer K, Winkler T, Heidenreich O, Ganser A, Eder M. (2003). Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood. 101, 1566-1569.

Schlechte HH, Schnorr D, Löning T, Rudolph BD, Pohrt UM, Loening SA. (1997). Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers – investigation by temperature gradient gel electrophoresis (TGGE). J Urol. 157, 1049-1053.

Schmid W. (1975). The micronucleus test. Mutat Res. 31, 9-15.

Schmit TL, Zhong W, Nihal M, Ahmad N. (2009). Polo-like kinase 1 (Plk1) in nonmelanoma skin cancers. Cell Cycle. 8, 2697–2702.

Schmit TL, Zhong W, Setaluri V, Spiegelman VS, Ahmad N. (2009). Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells. J Invest Dermatol. 129, 2843–2853.

Schneider WC. (1957). Determination of nucleic acid in tissues by pentose analysis. Methods Enzymol. 3, 680–684.

Schweitzer VG. (1993). Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope. 103, 1–52.

Seifried HE, Anderson DE, Fisher EI, Milner JA. (2007). A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem. 18, 567-579.

Seitz SJ, Schleithoff ES, Koch A, Schuster A, Teufel A, Staib F, Stremmel W, Melino G, Krammer PH, Schilling T, Müller M. (2010). Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway. Int J Cancer. 126, 2049-2066.

Serpi R, Piispala J, Jarvilehto M, Vahakangas K (1999). Thapsigargin has similar effect on p53 protein response to benzo(a)pyrene DNA adducts as TPA in mouse skin. Carcinogenesis 20: 1755–1760.

Shah MD, Iqbal M. (2010). Diazinon-induced oxidative stress and renal dysfunction in rats. Food Chem Toxicol. 48, 3345-3353.

Sharma A, Ramanjaneyulu A, Ray R, Rajeswari MR. (2009). Involvement of High Mobility Group B Proteins in Cisplatin-Induced Cytotoxicity in Squamous Cell Carcinoma of Skin. DNA Cell Biol. 28, 311–318.

Sharma R, Anmol. (2010). Encyclopaedia of Insect and Pesticide. viii, 304.

Sharma Y, Bashir S, Irshad M, Nag TC, Dogra TD. (2005). Dimethoate-induced effects on antioxidant status of liver and brain of rats following sub chronic exposure. Toxicology. 215, 173-181.

202

Sherr CJ, Roberts JM. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512.

Shi Z, Azuma A, Sampath D, Li YX, Huang P, Plunkett W. (2001). S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine. Cancer Res. 61, 1065–1072.

Shi Z, Liang YJ, Chen ZS. (2007). Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein. Oncol Rep. 17, 969-976.

Shishodia S, Aggarwal BB. (2004). Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-κB by suppressing activation of IκBα kinase in human non-small cell lung carcinoma: Correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. Cancer Res. 64, 5004-5012.

Shishodia S, Aggarwal BB. (2004). Nuclear factor-kappaB: a friend or a foe in cancer? Biochem Pharmacol. 68, 1071–1080.

Shukla Y, Prasad S, Tripathi C, Singh M, George J, Kalra N. (2007). In vitro and in vivo modulation of testosterone mediated alterations in apoptosis related proteins by [6]-gingerol. Mol Nutr Food Res. 51, 1492-1502.

Shukla Y, Antony M, Kumar S, Mehrotra NK. (1990). Carcinogenic Activity of a Carbamate Fungicide, Mancozeb on Mouse Skin. Cancer Lett. 53, 191-195.

Shukla Y, Arora A. (2001). Transplacental carcinogenic potential of the carbamate fungicide mancozeb. J Environ Pathol Toxicol Oncol. 20, 127-131.

Shukla Y, Singh M. (2007). Cancer preventive properties of ginger: A brief review. Food Chem Toxicol. 45, 683–690.

Sinha AK. (1972). Colorimetric assay of Catalase. Anal Biochem. 47, 389–394.

Sinicrope FA, Hart J, Michelassi F, Lee JJ. (1995). Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Clin Cancer Res. 1, 1103-1110.

Sivaraman VS, Wang H, Nuovo GJ, Malbon CC. (1997). Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest. 99, 1478–1483.

Skobe M, Hawighorst T, Jackson DG. (2001). Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 7, 192-198.

Skoufias DA, Mollinari C, Lacroix FB, Margolis RL. (2000). Human survivin is a kinetochore-associated passenger protein. J Cell Biol. 151, 1575-1582.

Soloneski S, Reigosa MA, Larramendy ML. (2003b). Vitamin E prevents ethylene bis(dithiocarbamate) pesticide zineb-induced sister chromatid exchange in Chinese hamster ovary cells. Mutagenesis. 18, 505-510.

Son Y, Cheong YK, Kim NH, Chung HT, Kang DG, Pae HO. (2011). Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways? J Signal Transduct. 2011:792639.

Sonoke S, Ueda T, Fujiwara K. (2008). Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes. Cancer Res. 68, 8843-8851.

Soussi T, Be´roud C. (2001). Assessing TP53 status in human tumours to valuate clinical outcome. Nat Rev Cancer. 1, 233–240.

Spa¨nkuch B, Matthess Y, Knecht R, Zimmer B, Kaufmann M, Strebhardt K. (2004). Cancer inhibition in nude mice after systemic application of U6 promoterdriven short hairpin RNAs against PLK1. J Natl Cancer Inst. 96, 862–872.

Spankuch B, Heim S, Kurunci-Csacsko E. Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo. 2006. Cancer Res. 66, 5836-5846.

Spankuch B, Kurunci-Csacsko E, Kaufmann M, Strebhardt K. (2007). Rational combinations of siRNAs targeting Plk1 with breast cancer drugs. Oncogene. 26, 5793-5807.

203

Spankuch B, Matthess Y, Knecht R, Zimmer B, Kaufmann M, Strebhardt K. (2004). Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1. J Natl Cancer Inst. 96, 862-872.

Spankuch-Schmitt B, Bereiter-Hahn J, Kaufmann M, Strebhardt K. (2002). Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J Natl Cancer Inst. 94, 1863-1877.

Spiewak R. Pesticides as a cause of occupational skin diseases in farmers. 2001. Ann Agric Environ Med. 8, 1-5.

Spitaleri G, Matei DV, Curigliano, Detti S, Verweij F, Zambito S, Scardino E, Rocco B, Nole` F, Ariu L, Pas TD, Braud FD, Cobelli OD. (2009). Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer. Ann Oncol. 20: 498–502.

Sporn MB. (1976). Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. 36, 2699–2702.

Sporn MB. (1996). The war on cancer. Lancet. 347, 1377-1381.

Steegmaier M, Hoffmann M, Baum A. (2007). BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol. 17, 316-322.

Steenland K, Cedillo L, Tucker J, Hines C, Sorensen K, Deddens J, Cruz V. (1997). Thyroid Hormones and Cytogenic Outcomes in Backpack Sprayers Using Ethylenebisdithiocarbamate (EBDC) Fungicides in Mexico. Environ Health Perspect. 105, 1126-1130.

Strebhardt K, Ullrich A. (2006). Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer. 6, 321-330.

Subbaramaiah K, Dannenberg AJ. (2003). Cyclooxygenase-2: A molecular target for chemoprevention and treatment. Trends Pharmacol. Sci. 24, 96-102.

Sugiura T, Inoue Y, Matsuki R. (2009). VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker. Int J Oncol. 34, 673-80.

Sumitomo M, Ohba M, Asakuma J, Asano T, Kuroki T, Hayakawa M. (2002). Protein kinase

Invest. 109, 827-836.

Surh YJ, Park KK, Chun KS, Lee LJ, Lee E, Lee SS. (1999). Anti-tumor-promoting activities of selected pungent phenolic substances present in ginger. J Environ Pathol Toxicol Oncol. 18, 131-139.

Szkolnik M. (1981). Physical modes of action of sterol inhibiting fungicides against apple diseases. Plant Dis. 65, 981-985.

Takai N, Hamanaka R, Yoshimatsu J, Miyakawa I. (2005). Polo-like kinases (Plks) and cancer. Oncogene. 24, 287–291.

Takimoto CH, Calvo E. (2008). Principles of Oncologic Pharmacotherapy. In: Cancer Management: A Multidisciplinary Approach. 11 ed. (Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ eds.). UBM Medica, London, UK. pp. 42–58.

Talpaz M, Shah NP, Kantarjian H. (2006). Dasatinib in imatinibresistant Philadelphia chromosome-positive leukemias. N Engl J Med. 354, 2531-2541.

Talpaz M, Silver RT, Druker BJ. (2002). Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood. 99, 1928-1937.

Tamura K, Sudo T, Senftleben U, Dadak AM, Johnson R, Karin M. (2000). Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell. 102, 221-231.

Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. (2000). Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 6, 127-134.

204

Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW. (2011). Rotenone, Paraquat and Parkinson’s Disease. Environ Health Perspect. 119, 866-872.

Terzi A, Iraz M, Sahin S, Ilhan A, Idiz N, Fadillioglu E. (2004). Protective effects of erdosteine on rotenone-induced oxidant injury in liver tissue. Toxicol Ind Health. 20, 141-147.

Thorey IS, Roth J, Regenbogen J, Halle JP, Bittner M, Vogl T, Kaesler S, Bugnon P, Reitmaier B, Durka S, Graf A, Wöckner M, Rieger N, Konstantinow A, Wolf E, Goppelt A, Werner S. (2001). The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem 276, 35818–35825.

Tirro E, Consoli ML, Massimino M. (2006). Altered expression of c- IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells. Cancer Res. 66, 4263-4272.

Toledano MB, Leonard WJ. (1991). Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. U.S.A. 88, 4328-4332.

Toualbi-Abed K, Daniel F, Güller MC, Legrand A, Mauriz JL, Mauviel A, Bernuau D. (2008) Jun D cooperates with p65 to activate the proximal kappaB site of the cyclin D1 promoter: role of PI3K/PDK-1. Carcinogenesis. 29, 536-543.

Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN,Flavell RA, Davis RJ. (2000). Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science. 288, 870–874.

Towbin H, Staehelin T, Gordon J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354.

Trojan L, Kiknavelidze K, Knoll T, Alken P, Michel MS. (2005) Prostate cancer therapy: standard management, new options and experimental approaches. Anticancer Res. 25, 551- 561.

Tsujimoto Y, Cossman J, Jaffe E, Croce CM. (1985). Involvement of the bcl-2 gene in human follicular lymphoma. Science. 228, 1440-1443.

Tsuruta T, Oh-Hashi K, Ueno Y, Kitade Y, Kiuchi K, Hirata Y. (2007). RNAi knockdown of caspase-activated DNase inhibits rotenone-induced DNA fragmentation in HeLa cells. Neurochem Int. 50, 601-606.

Tyagi S, Bhui K, Singh R, Singh M, Raisuddin S, Shukla Y. (2010). Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells. Biochem Pharmacol. 80, 1326-1334.

Tyagi S, George J, Singh R, Bhui K, Shukla Y. (2011). Neoplastic alterations induced in Mammalian skin following mancozeb exposure using in vivo and in vitro models. OMICS. 15,155-167.

USEPA. (2005a). Reregistration Eligibility Decision for Mancozeb. EPA 738-R-04-012, Environmental Protection and Toxic Substances. U.S. Environmental Protection Agency. Washington, DC.

USEPA. (2005b). Mancozeb Facts, EPA 738-F-05-XX in Prevention, Pesticides and Toxic Substances (7508C). United States Environmental Protection Agency. Washington, DC.

USEPA. (1987). Pesticide fact sheet: Mancozeb. Registration Standard. Office of Pesticides and Toxic Substances. Office of Pesticide Programs. U.S. Environmental Protection Agency Washington, DC.

USEPA. (1999). Reconocimiento y Manejo de los Envenenamientos por Pesticidas. Office of Prevention, Pesticides, and Toxic Substances. U.S. Environmental Protection Agency Washington, DC.

Vagefi PA, Longo WE. (2005). Colorectal cancer in patients with inflammatory bowel disease. Clin Colorectal Cancer, 4, 313–319.

205

Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39, 44–84.

van de Weerdt BC, Medema RH. (2006). Polo-like kinases: a team in control of the division. Cell Cycle. 5, 853-864.

Van Maele-Fabry G, Lantin AC, Hoet P, Lison D. (2010). Childhood leukaemia and parental occupational exposure to pesticides: a systematic review and meta-analysis. Cancer Causes Control. 21, 787–809.

van Vugt MA, Bra` s A, Medema RH. (2005). Restarting the cell cycle when the checkpoint comes to a halt. Cancer Res. 65, 7037–7040.

Van Wyk BE, Van Oudtshoorn B, Gericke N. Medicinal Plants of South Africa. 2002. 2nd ed. Briza Publications, South Africa.

Vayssade M, Haddada H, Faridoni-Laurens L, Tourpin S, Valent A, Bénard J, Ahomadegbe JC. (2005). P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells. Int J Cancer. 116, 860-869.

Ventura JJ, Tenbaum S, Perdiguero E, Huth M, Guerra C, Barbacid M, Pasparakis M, Nebreda AR. (2007). p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet. 39, 750-758.

Verma UN, Surabhi RM, Schmaltieg A, Becerra C, Gaynor RB. (2003). Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res. 9, 1291-1300.

Voeller HJ, Sugars LY, Pretlow T, Gelmann EP. (1994). p53 oncogene mutations in human prostate cancer specimens. J Urol. 151, 492-495.

Vogel CF, Li W, Sciullo E, Newman J, Hammock B, Reader JR, Tuscano J, Matsumura F. (2007).Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. Am J Pathol. 171, 1538-1548.

Volz A, Korge BP, Compton JG, Ziegler A, Steinert PM, Mischke D. Physical mapping of a functional cluster of epidermal differentiation genes on chromosome 1q21. Genomics 18:92–99, 1993.

Wagner ED, Anderson D, Dhawan A, Rayburn AL, Plewa MJ. (2003). Evaluation of EMS-induced DNA damage in the single cell gel electrophoresis (Comet) assay and with flow cytometric analysis of micronuclei. Teratog. Carcinog. Mutagen. 23, 1–11.

Wallace JM. (2002). Nutritional and botanical modulation of the inflammatory cascade – eicosanoids, cyclooxygenases, and lipoxygenases – as an adjunct in cancer therapy. Integr. Cancer Ther. 1, 7–37.

Wang CY, Mayo MW, Baldwin AS Jr. (1996). TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science. 274, 784-787.

Wang R, Li B, Wang X, Lin F, Gao P, Cheng SY, Zhang HZ. (2009) Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line. Auris Nasus Larynx. 36, 332-339.

Wang S, Liu H, Ren L, Pan Y, Zhang Y. (2008). Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference. Neoplasia. 10, 399-407.

Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S, Sun P. (2002). Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol. 22, 3389-3403.

Wang W, Kim SH, El-Deiry WS. (2006). Small-molecule modulators of p53 family signalling and antitumor effects in p53-deficient human colon tumor xenografts. Proc Natl Acad Sci. USA. 103, 11003 – 11008.

Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW, Tan HS, Lee KS, Loong S, Sethi V, Chua EJ, Machin D. (2005). Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with

206

American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol. 23, 6730-6738.

Wei H. (1992). Activation of oncogenes and/or inactivation of anti-oncogenes by reactive oxygen species. Med Hypotheses. 39, 267-270.

Wei M, Wanibuchi H, Morimura K, Iwai S, Yoshida K, Endo G, Nakae D, Fukushima S. (2002). Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis. 23, 1387-1397.

Weichert W, Schmidt M, Gekeler V, Denkert C, Stephan C, Jung K, Loening S, Dietel M, Kristiansen G. (2004). Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate. 60, 240-245.

Weng D, Song X, Xing H, Ma X, Xia X, Weng Y, Zhou J, Xu G, Meng L, Zhu T, Wang S, Ma D. (2009). Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells. Cancer Lett. 273, 257–265.

Weterman MA, Stoopen GM, van Muijen GN, Kuz´nicki J, Ruiter DJ, Bloemers HP. (1992). Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. Cancer Res. 52, 1291–1296.

Whitmarsh AJ, Yang SH, Su MS, Sharrocks AD, Davis RJ. (1997). Role of p38 and JNK mitogen-

activated protein kinases in the activation of ternary complex factors. Mol Cell Biol. 17, 2360-2371.

WHO. 1997. Codex Alimentarius Commission, Progress report by WHO, CX/PR 98/5.

WHO. 2,4-D Environmental Aspects. 1989. Geneva, Switzerland.

WHO (2000). WHO recommended classification of pesticides by hazard and guidelines to classification. 2000-01, Geneva. World Health Organization (document reference WHO/PCS/01.4)

WHO, 4th May 2010. http://www.who.int/uv/faq/skincancer/en/index1.html.

WHO, (2003), Global cancer rates could increase by 50% to 15 million by 2020 http://www.who.int/mediacentre/news/releases/2003/pr27/en/

WHO, (2007), WHO calls for prevention of cancer through healthy workplaces, http://www.who.int/mediacentre/news/notes/2007/np19/en/index.html

WHO. (2009). Regional Office for South-East Asia. Health implications from monocrotophos use: a review of the evidence in India. New Delhi. http://203.90.70.117/ PDS_DOCS/B4293.pdf

Wicki R, Marenholz I, Mischke D, Schäfer BW, Heizmann CW. (1996). Characterization of the human S100A12 (calgranulin C, p6, CAAF1, CGRP) gene, a new member of the S100 gene cluster on chromosome 1q21. Cell Calcium 20:459–464.

Wicks T, Lee TC. (1982). Evaluation of fungicides applied after infection for control of Plasmopara viticola on grapevine. Plant Dis. 66, 839-841.

Wilda M, Fuchs U, Wossmann W, Borkhardt A. (2002). Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene. 21, 5716-5724.

Winkles JA, Alberts GF. (2005). Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues. Oncogene. 24, 260-266.

Wodarz A, Nusse R. (1998). Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol. 14, 59-88.

Wolf G, Elez R, Doermer A. (1997). Prognostic significance of pololike kinase (PLK) expression in non-small cell lung cancer. Oncogene. 14, 543-549.

Wolf R, Mirmohammadsadegh A, Walz M, Lysa B, Tartler U, Remus R, Hengge U,Michel G, Ruzicka T. (2003). Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family. FASEB J. 17, 1969– 1971,

Wolfe HR, Armstrong JF, Durham WF. (1966). Pesticide exposure from concentrate spraying. Arch Environ Health. 13, 340-344.

207

Wong CM, Fan ST, Ng IO. (2001). Beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer. 92,136-145.

Wong FP, Wilcox WF. (2001). Comparative physical modes of action of azoxystrobin, mancozeb, and metalaxyl against Plasmopara viticola (grapevine downy mildew). Plant Dis. 85, 649-656.

Wong PS, Matsumura F. (2007). Promotion of breast cancer by beta-hexachlorocyclohexane in MCF10AT1 cells and MMTV-neu mice. BMC Cancer. 7, 130.

Woo YT, Lai DY (2003). Mechanisms of action of chemical carcinogens, and their role in Structure-Activity Relationships (SAR) analysis and risk assessment. In: Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens. (Benigni R, ed). Boca Raton: CRC Press, 41–80.

www.sirna.com/sirnaproduct/sirna 027.html;www.acuitypharma.com/press.asp).

Xia Z, Zhu Z, Zhang L. (2008). Specific reversal of MDR1/P-gpdependent multidrug resistance by RNA interference in colon cancer cells. Oncol Rep. 20, 1433-1439.

Xing C, Imagawa W. (1999). Altered MAP kinase (ERK1, 2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF. Carcinogenesis. 20, 1201– 1208.

Xing H, Cao Y, Weng D, Tao W, Song X, Wang W, Meng L, Xu G, Zhou J, Wang S, Ma D. (2008). Fibronectin-mediated activation of Akt2 protects human ovarian and breast cancer cells from docetaxel induced apoptosis via inhibition of the p38 pathway. Apoptosis. 13, 213-223.

Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. (2000). Vascular-specific growth factors and blood vessel formation. Nature. 407, 242-248.

Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD. (1998). p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing and dominant-negative activities. Mol Cell. 2, 305-316.

Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F. (1999). P63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 398, 714–718.

Yang C, Cirielli C, Capogrossi MC, Passaniti A. (1995). Adenovirus mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res. 55, 4210-4213.

Yang X, Li H, Zhou Z, Wang WH, Deng A, Andrisani O, Liu X. (2009). Plk1-mediated phosphorylation of Topors regulates p53 stability. J Biol Chem. 284, 18588-18592.

Yang Y, Kaul S, Zhang D, Anantharam V, Kanthasamy AG. (2004). Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration. Mol Cell Neurosci. 25, 406-421.

Yano J, Hirabayashi K, Nakagawa S. (2004). Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer. Clin Cancer Res. 10, 7721-7726.

Yarsan E, Tanyuksel M, Celik S, Aydin A. (1999) Effects of Aldicarb and Malathion on Lipid Peroxidation. Bull Environ Contam Toxicol. 63, 575-581.

Yoshida K. (1989). Cutaneous exposure of pesticide spray applicators. In: Principles of Health and Safety in Agriculture. (Dosman JA, Cockcroft D eds.). CRC Press, Boca Raton.

Ysebaert L, Chicanne G, Demur C. (2006). Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia. 20, 1211-1216.

Yu C, Zhang X, Sun G. (2008). RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells. J Cell Mol Med. 12, 2334-2349.

208

Yu M, Cai L, Liang M, Huang Y, Gao H, Lu S, Fei J, Huang F. (2009). Alteration of NRSF expression exacerbating 1-methyl-4-phenyl-pyridinium ion-induced cell death of SH-SY5Y cells. Neurosci Res. 65, 236-244.

Yuan G, Wahlqvist ML, He G, Yang M, Li D. (2006). Natural products and anti-inflammatory activity. Asia Pac. J. Clin. Nutr. 15, 143-152.

Yuan ZQ, Feldman RI, Sussman GE, Coppola D, Nicosia SV, Cheng JQ. (2003). AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol Chem. 278, 23432–23440.

Yuspa SH, Poirier MC. (1988). Chemical carcinogenesis: from animal models to molecular models in one decade. Adv Cancer Res. 50, 25-70.

Zama LD, Meraihi Z, Tebibel S, Benayssa W, Benayache F, Benayache S, Vlietinck AJ. (2007). Chlorpyrifos-induced oxidative stress and tissue damage in the liver, kidney, brain and fetus in pregnant rats: The protective role of the butanolic extract of Paronychia argentea. Indian J. Pharmacol. 39, 145-150.

Zhang M, Latham DE, Delaney MA, Chakravarti A. (2005). Survivin mediates resistance to antiandrogen therapy in prostate cancer. Oncogene. 24, 2474–2482.

Zhang X, Jhang J, Yang X, Han X. (2007). Several transcription factors regulate COX-2 gene expression in pancreatic β cells. Mol Biol Rep. 34, 199- 206.

Zhou J, Hu G, Herring BP. (2005). Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1. Mol Cell Biol. 25, 9874-9885.

Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K. (1999). Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59, 198–204.